April 26, 2025 4:51 PM

Latest:

Orogen Royalties: Triple Flag’s $421 Million Acquisition
Lumina Gold’s $581 Million Buyout: The Start of A Junior Mining M&A Wave?
Elemental Altus Q4 Earnings: How $3,300 Gold Rescued a Missed Production Target
Newmont Q1 Earnings: Gold Boom Masks Production Problems
A Heart Disease Cure For Pericarditis? Phase 3 Trial Advances | David Elsley – Cardiol Therapeutics

the deep dive

Providing stock analysis for investors of the Canadian junior markets

Home
Latest
- Automotive
- Cannabis
- Commentary
- Full Analysis
- Gold
- Industrials
- Macro
- Oil
- Resources
- Technology
Resources
Energy
Technology
Coverage Companies
Verses AI
About
Contact Us

UNC Frat Boys Get Close to $350,000 from A GoFundMe Campaign for Protecting US Flag from Protestors

Latest

Orogen Royalties: Triple Flag’s $421 Million Acquisition
Lumina Gold’s $581 Million Buyout: The Start of A Junior Mining M&A Wave?
Elemental Altus Q4 Earnings: How $3,300 Gold Rescued a Missed Production Target
Newmont Q1 Earnings: Gold Boom Masks Production Problems
A Heart Disease Cure For Pericarditis? Phase 3 Trial Advances | David Elsley – Cardiol Therapeutics
How One Mining Stock Delivered 3,200% Returns | Wojtek Wodzicki – NGEx Minerals
Long Live the King? Canadians Would Rather Rejoin British Empire Than Become 51st US State
Alberta Environment Minister Accuses Carney Of Disguising Climate Agenda As ‘Energy Superpower’ Push

Video

Orogen Royalties: Triple Flag’s $421 Million Acquisition

April 26, 2025 3:33 PM Jay Lutz 0

Without jinxing it.. We may finally, actually, be at the start of a potential bull market in the junior mining

Trudeau’s Decision to Sell Canada’s Gold Reserves Has Now Cost Canada Over $149 million
WeightWatchers Prepares For Bankruptcy Protection As It Loses Ground to Ozempic
Trump Slashes Energy & Mining Permitting Timelines Down To 28 Days
Shipping Collapse Accelerates as Tariffs Trigger COVID-Level Disruption
BMO Ends Partnership with Cathie Wood's ARK Investment, Shutters Funds

News

Biotech Latest News

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial

April 17, 2025 7:59 AM Jay Lutz 0

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been enrolled into a phase III clinical trial for its lead drug candidate, CardiolRx™.

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek

April 16, 2025 8:29 AM Jay Lutz 0

Canadian Copper To Begin Exploration At Murray Brook East

April 15, 2025 10:30 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Leave a ReplyCancel reply